BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 12774132)

  • 1. "Real World" compliance with strategies to prevent early-onset group B streptococcal disease.
    Riley L; Appollon K; Haider S; Chan-Flynn S; Cohen A; Ecker J; Rein M; Lieberman E
    J Perinatol; 2003 Jun; 23(4):272-7. PubMed ID: 12774132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
    Pinto NM; Soskolne EI; Pearlman MD; Faix RG
    J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.
    Lin FY; Brenner RA; Johnson YR; Azimi PH; Philips JB; Regan JA; Clark P; Weisman LE; Rhoads GG; Kong F; Clemens JD
    Am J Obstet Gynecol; 2001 May; 184(6):1204-10. PubMed ID: 11349189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.
    Schrag SJ; Zell ER; Lynfield R; Roome A; Arnold KE; Craig AS; Harrison LH; Reingold A; Stefonek K; Smith G; Gamble M; Schuchat A;
    N Engl J Med; 2002 Jul; 347(4):233-9. PubMed ID: 12140298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with a risk factor-based intrapartum prophylaxis program for neonatal group B streptococcal disease.
    McIlwaine K; Kneebone K; Barkehall-Thomas A; Wallace EM
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):199-201. PubMed ID: 16704472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with protocols for prevention of neonatal group B streptococcal sepsis: practicalities and limitations.
    Gilbert GL; Hewitt MC; Turner CM; Leeder SR
    Infect Dis Obstet Gynecol; 2003; 11(1):1-9. PubMed ID: 12839627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of universal antenatal screening for group B streptococcus.
    Van Dyke MK; Phares CR; Lynfield R; Thomas AR; Arnold KE; Craig AS; Mohle-Boetani J; Gershman K; Schaffner W; Petit S; Zansky SM; Morin CA; Spina NL; Wymore K; Harrison LH; Shutt KA; Bareta J; Bulens SN; Zell ER; Schuchat A; Schrag SJ
    N Engl J Med; 2009 Jun; 360(25):2626-36. PubMed ID: 19535801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with a protocol for intrapartum antibiotic prophylaxis against neonatal group B streptococcal sepsis in women with clinical risk factors.
    Sanders TR; Roberts CL; Gilbert GL
    Infect Dis Obstet Gynecol; 2002; 10(4):223-9. PubMed ID: 12648317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
    Akker-van Marle ME; Rijnders ME; Dommelen P; Fekkes M; Wouwe JP; Amelink-Verburg MP; Verkerk PH
    BJOG; 2005 Jun; 112(6):820-6. PubMed ID: 15924544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset group B streptococcal disease in the era of maternal screening.
    Puopolo KM; Madoff LC; Eichenwald EC
    Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening.
    Konrad G; Katz A
    Can Fam Physician; 2007 Jun; 53(6):1055, 2001:e.1-6, 1054. PubMed ID: 17872785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.
    Renner RM; Renner A; Schmid S; Hoesli I; Nars P; Holzgreve W; Surbek DV
    J Perinat Med; 2006; 34(1):32-8. PubMed ID: 16489884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols.
    Main EK; Slagle T
    Am J Obstet Gynecol; 2000 Jun; 182(6):1344-54. PubMed ID: 10871448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A complete audit cycle of intrapartum group B streptococcus prophylaxis.
    McCord N; Owen P; Powls A; Lunan B
    Health Bull (Edinb); 2001 Jul; 59(4):263-7. PubMed ID: 12664737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study to prevent early-onset Group B Streptococcal disease in newborns.
    Jefferson UT
    Adv Neonatal Care; 2006 Aug; 6(4):208-19. PubMed ID: 16890133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis.
    Rausch AV; Gross A; Droz S; Bodmer T; Surbek DV
    J Perinat Med; 2009; 37(2):124-9. PubMed ID: 19021455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.
    Schrag SJ; Zywicki S; Farley MM; Reingold AL; Harrison LH; Lefkowitz LB; Hadler JL; Danila R; Cieslak PR; Schuchat A
    N Engl J Med; 2000 Jan; 342(1):15-20. PubMed ID: 10620644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection.
    Yancey MK; Duff P
    Obstet Gynecol; 1994 Mar; 83(3):367-71. PubMed ID: 8127527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis.
    Pulver LS; Hopfenbeck MM; Young PC; Stoddard GJ; Korgenski K; Daly J; Byington CL
    J Perinatol; 2009 Jan; 29(1):20-5. PubMed ID: 18704032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of different prevention strategies on neonatal group B streptococcal disease.
    Vergani P; Patanè L; Colombo C; Borroni C; Giltri G; Ghidini A
    Am J Perinatol; 2002 Aug; 19(6):341-8. PubMed ID: 12357426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.